bezafibrate has been researched along with Tauopathies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beal, MF; Calingasan, NY; Chan, RB; Di Paolo, G; Dumont, M; Elipenahli, C; Gerges, M; Jainuddin, S; Pujol, A; Stack, C; Starkov, AA; Starkova, N; Tampellini, D; Yang, L | 1 |
1 other study(ies) available for bezafibrate and Tauopathies
Article | Year |
---|---|
Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice.
Topics: Adipose Tissue, Brown; Animals; Behavior, Animal; Bezafibrate; Disease Models, Animal; Energy Metabolism; Fatty Acids; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Inflammation; Mice; Mice, Transgenic; Oxidation-Reduction; Oxidative Stress; Phosphorylation; tau Proteins; Tauopathies | 2012 |